日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immunogenicity risk assessment for tailored mitigation and monitoring of biotherapeutics during development: recommendations from the European Immunogenicity Platform

针对生物治疗药物研发过程中的免疫原性风险评估,制定个性化缓解措施并进行监测:欧洲免疫原性平台的建议

Grudzinska-Goebel, Joanna; Benstein, Karin; Bloem, Karien; Cowan, Kyra J; Gorovits, Boris; Jadhav, Maria; Janssen, Melody; Jawa, Vibha; Kiessling, Andrea; Kramer, Daniel; Kromminga, Arno; van der Linden, Marcel; Liu, Susana; Lotz, Gregor P; Luo, Linlin; Malisauskas, Mantas; Marban-Doran, Céline; Mytych, Daniel T; Oquendo Cifuentes, Elisa; Pippig, Susanne; Ribes, Sandra; Rouwette, Myrthe; Shao, Weiping; Tourdot, Sophie; Weldingh, Karin Nana; Snoeck, Veerle

2025 White Paper on Recent Issues in Bioanalysis: Redosing Patients with AAV Gene Therapy; CRS Immunogenicity Risk; Shedding Assays; NHP Studies Immunogenicity; CMC vs Bioanalytical Assays; Artificial Intelligence-Powered Genomic Pipelines for NGS (PART 3A - Recommendations on Gene, Cell, and Vaccine Therapies Immunogenicity & Technologies; Biotherapeutics & Biosimilars Immunogenicity Assessment & Clinical Relevance PART 3B - Regulatory Agencies' Input on Immunogenicity/Technologies of Biothera

2025 年生物分析最新问题白皮书:AAV 基因治疗患者的重复给药;细胞因子释放综合征 (CRS) 免疫原性风险;脱落检测;非人灵长类动物 (NHP) 研究的免疫原性;CMC 与生物分析检测;人工智能驱动的 NGS 基因组流程(第 3A 部分 - 关于基因、细胞和疫苗疗法免疫原性及技术的建议;生物治疗药物和生物类似药的免疫原性评估及临床相关性;第 3B 部分 - 监管机构对 Biothera 免疫原性/技术的意见)

Tounekti, Omar; Shubow, Sophie; Wassmer, Sarah; Van Tuyl, Andrea; Yang, Lin; Gong, Binsheng; Abhari, Mohsen Rajabi; Kalina, Warren; Myler, Heather; DelCarpini, Jason; Escobar, David; Fiscella, Michele; Gorovits, Boris; Gupta, Swati; Irvin, Susan C; Irwin, Chad; Jankowski, Wojciech; Jawa, Vibha; Karauzum, Hatice; Kerridge, Claire; Lu, Yanmei; Mayer, Christian; McGregor, Jessica; Melton, Andrew; Murphy, Rocio; Nanra, Jasdeep; Nowocin, Anna; Partridge, Michael A; Prior, Sandra; Sauna, Zuben; Scott, Bradley; Seitzer, Jessica; Stern, Mark; Sugimoto, Hiroshi; Taylor, Melissa; Wong, Adrian; Xiao, Wenming; Xu, Yuanxin; Yang, Tong-Yuan; Yuill, Daisy; Kubiak, Robert J; Thway, Theingi; Gunn, George; Pelto, Ryan; Sumner, Giane; Baltrukonis, Daniel; Dholakiya, Sanjay L; Dogmanits, Shannon; Garofolo, Fabio; Jadhav, Maria; Kramer, Daniel; Meyer, Erik; Mohapatra, Susovan; Mozaffari, Reza; Peng, Kun; Pine, Samuel; Poetzl, Johann; Rasamoelisolo, Michele; Shao, Weiping; Staack, Roland F; Swanson, Steven; Taqui, Atiya; Vauleon, Stephanie; Wang, Yun; Wen, Yi

Immunogenicity assessment strategy for a chemically modified therapeutic protein in clinical development.

针对处于临床开发阶段的化学修饰治疗蛋白的免疫原性评估策略

Hagman Charlotte, Chasseigne Gaetan, Nelson Robert, Anlauff Florian, Kagan Mark, Goldfine Allison B, Terszowski Grzegorz, Jadhav Maria

Developmental Syngap1 Haploinsufficiency in Medial Ganglionic Eminence-Derived Interneurons Impairs Auditory Cortex Activity, Social Behavior, and Extinction of Fear Memory

内侧神经节隆起衍生的中间神经元中发育性 Syngap1 单倍体不足会损害听觉皮层活动、社交行为和恐惧记忆的消退

Vidya Jadhav, Maria Isabel Carreno-Munoz, Pegah Chehrazi, Jacques L Michaud, Bidisha Chattopadhyaya, Graziella Di Cristo

Opposing roles of endothelial and leukocyte-expressed IL-7Rα in the regulation of psoriasis-like skin inflammation

内皮细胞和白细胞表达的IL-7Rα在调节银屑病样皮肤炎症中发挥相反的作用

Vranova, Martina; Friess, Mona C; Haghayegh Jahromi, Neda; Collado-Diaz, Victor; Vallone, Angela; Hagedorn, Olivia; Jadhav, Maria; Willrodt, Ann-Helen; Polomska, Anna; Leroux, Jean-Christophe; Proulx, Steven T; Halin, Cornelia